ArticleMolecular and clinical oncology2018

Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports.

Tadahiro Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.